Literature DB >> 6680324

Spasmolytic activity of some 4-methylumbelliferone derivatives.

C Stacchino, R Spanò, A Pettiti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6680324

Source DB:  PubMed          Journal:  Boll Chim Farm        ISSN： 0006-6648


× No keyword cloud information.
  3 in total

1.  Dietary supplement hymecromone and sorafenib: a novel combination for the control of renal cell carcinoma.

Authors:  Anaid Benitez; Travis J Yates; N Shamaldevi; Tim Bowen; Vinata B Lokeshwar
Journal:  J Urol       Date:  2012-12-07       Impact factor: 7.450

Review 2.  4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.

Authors:  Nadine Nagy; Hedwich F Kuipers; Adam R Frymoyer; Heather D Ishak; Jennifer B Bollyky; Thomas N Wight; Paul L Bollyky
Journal:  Front Immunol       Date:  2015-03-23       Impact factor: 7.561

3.  Crucial role of hyaluronan in neointimal formation after vascular injury.

Authors:  Yuichiro Kashima; Masafumi Takahashi; Yuji Shiba; Naoki Itano; Atsushi Izawa; Jun Koyama; Jun Nakayama; Shun'ichiro Taniguchi; Koji Kimata; Uichi Ikeda
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.